BIOBANKING FOR MEDICAL R&D MARKET REPORT

Do you want to know the prospects for biobanking in medical research, pharmaceutical R&D and personalised medicine? Our new study shows you its technological and commercial potential. You can have that report today, staying ahead. Demand for biobanking has been expanding. There will be commercial growth, with important trends to watch from 2010 onwards.

Our report shows how you can benefit. As the pharmaceutical industry shifts towards personalised medicine, there is a need for usable, well-maintained biospecimen collections. We show you where the biobanking sector is heading, forecasting its technological and commercial potential from 2010 onwards.

Biobanking for Medical R&D: Technology and Market 2010-2025 reveals the opportunities and challenges the biobanking sector will face. These include consolidation and harmonisation of biobanking practices. Advances in genetic research, stem cell research and regenerative medicine increase the importance of biobanking, as well as its commercial potential.

Our report provides data on current and future revenue values for the biobanking sector, globally and nationally. You will find that information only there. We cover both the for-profit and non-profit sectors. We analyse strengths, weaknesses and revenue trends for biobanking from 2010 to 2025. You can discover the sector’s prospects today.

Biobanked collections are increasingly valued by medical researchers and drug developers worldwide. What are the potential benefits to the pharma industry? How will biobanking product and service providers benefit? Our new report gives you answers and trends, saving you time and aiding your decisions.

Analysis of the world biobanking industry and market to meet your needs

Our new report examines the biobanking sector for medical R&D critically. We harness primary and secondary research to meet your needs. We provide revenue forecasts, market share analyses and other data. You will discover market strengths, weaknesses, opportunities and threats. We include over 45 tables and figures and an expert interview, as shown in the lists that follow. This is a market- and industry-centred study, with analyses and opinion to benefit your work.

Read » Biobanking for Medical R&D Market Report

Published 1 hour 37 min ago – Made popular 2 min 55 sec ago
Category: Business | Tags:

Login or register to post comments

Stories similar to Biobanking for Medical R&D Market Report:

Additional information on Biobanking for Medical R&D; Market Report :
- Aug 19, 2010 ... Biobanking 2012. As researchers strive to develop more personalised medicines, the acquisition of high quality biospecimens is vital. This is ...
- Nov 22, 2012 ... [281 Pages Research Report] Biobank (Biospecimen/ ... http://www. marketsandmarkets.com/Market-Reports/biopreservation-media-storage- equipment ... medical devices, pharmaceuticals, semiconductor and electronics, and ...
- Aug 29, 2012 ... See more news releases in Biometrics | Biotechnology | Medical ... This report analyzes emerging biobanking markets, by specific disease ...
- Jan 30, 2012 ... A new report predicts that world medical biobanking revenues will reach $19.1bn in 2015. That market generated $9.0bn in 2010, according to ...
- [281 Pages Report] Biobank (biospecimen/ biorepository/biopreservation) Market ... TABLE 60 REGENERATIVE MEDICINE MEDIA MARKET REVENUE, BY ...
- Biobanks have invoked questions on research ethics and medical ethics, and ..... .com/Report/734/Biobanking-for-Medicine-Technology-and-Market-2012-2022 ...
- Biobanking for Medical R&D: Technology and Market 2010-2025, Report Details – how will biobanking develop and contribute to healthcare? Our new report ...
- Dec 13, 2011 ... What does the future hold for biobanks? Visiongain's report shows you potential revenues and trends to 2022. Find data, forecasts and ...

Related links about Biobanking for Medical R&D; Market Report :
1. Biobanking for Medicine: Technology and Market 2012-2022 ...
2. Biobanking for Medical R&D: Technology and Market ... - Visiongain
3. Biobanking for Medical R&D: Technology and ... - Reportlinker.com
4. Biobank Market (Biospecimen/Biorepository/Biopreservation) Market ...
5. Biobank - Wikipedia, the free encyclopedia

Pharmaceutical Contract Manufacturing Report 1 hour 42 min ago

How will the contract manufacturing sector adapt to the needs of pharma from 2010 onwards? Our new report will show you trends and prospects there. How will the sector and its customers face challenges and opportunities? We show commercial benefits for the pharma contract manufacturing sector and its customers, including revenue trends for 2010-2025. You can have that report today, staying ahead.

Oncology Market Leaders Analyses and Outlook 2 years 48 weeks ago

Cancer treatment is a global healthcare priority, one with rising therapeutic and commercial importance. Over 20 million new cases of cancer are predicted in 2025, compared with 12 million in 2008 (WHO). Furthermore, anti-cancer drug sales exceeded $50bn worldwide in 2009. The oncology drug market has grown impressively, driven by rising disease prevalence, expanding patient populations and technological advances, especially in biomolecular medicine. Current treatments are better-tolerated, more- effective and more-commercially-successful than ever before, our latest report shows.

The World Dermatological Market Outlook 2010-2024 3 years 4 weeks ago

The dermatological drug market continues to be important and competitive globally. New treatments for skin disorders and increasing disease prevalence will lead to further expansion of that market area, we predict. There are potential gains in all the main aspects of pharma development: novel drugs, drug delivery innovation, generics and biotechnology. Our brand new report - The World Dermatological Market Outlook 2010-2024 - explains why that market will expand, revealing where the most-exciting developments will lie during our forecast period. And how you can benefit from this expansion.

World Multiple Myeloma Drug Treatment Market 7 weeks 4 days ago

Bharat Book Bureau has announced the addition of the "World Multiple Myeloma Drug Treatment Market 2012-2022" report to their offering.

See what the future holds for products to treat multiple myeloma. Visiongain's updated report gives you revenue predictions to 2022. There you find data, trends, opportunities and commercial prospects.

Our study lets you assess forecasted sales at overall world market, product and national level. Those analyses help you see the future of that industry and market.

Therapeutic Monoclonal Antibodies Market 1 hour 41 min ago

How will the market for monoclonal antibody (mAb) therapies perform from 2011? Visiongain's report shows you potential revenues to 2021. Find opportunities and prospects.

How will competition affect the mAb industry and market? Which national markets have the greatest potential for growth? You can find predictions and explanations in this study. It covers cancer, autoimmune diseases and other applications for therapeutic mAbs.